22 May 2013
Keywords: pfizer, signs, 165m, deal, psivida, global, drug
Article | 16 April 2007
Global drug behemoth Pfizer, which has had several R&D pipeline disappointments and is beginning to suffer generic competition for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 April 2007
21 May 2013
© 2013 thepharmaletter.com